MedTech Dive September 12, 2022
Nick Paul Taylor

Dive Brief:

  • Google parent company Alphabet has led a $1 billion investment in its health technology business Verily, positioning it to forge ahead with its new focus on precision health.
  • Verily is now focused on using data from a wide variety of sources to determine the best intervention for a person or community.
  • The $1 billion will support initiatives including real world evidence generation and healthcare data platforms that underpin the precision health strategy, strengthening Verily’s position at a time when tech companies such as Amazon, Apple and Microsoft are targeting healthcare.

Dive Insight:

Verily, then known as Google Life Sciences, emerged from the semi-secret Google X R&D group in 2015. Since then, the company has made headlines...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Pharma / Biotech, Precision Medicine, Trends
Revolutionizing Primary Care: The Role of Pharmacogenomics and AI in Personalized Medicine
BioAro Announces Real Time DNA Decoding Technology
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future

Share This Article